Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A medical worker holds a dose of the Sinovac vaccine at a district health facility as Indonesia begins mass ...

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal ...

Add Yahoo as a preferred source to see more of our stories on Google. People who were originally fully vaccinated with the Chinese-made Sinovac COVID-19 vaccine were shown to develop a high degree of ...

Intends to file definitive proxy materials in the coming days SINOVAC’s Board of Directors (the “SINOVAC Board”) also issued a letter to shareholders. The full text of the letter follows: Dear SINOVAC ...

BEIJING, Sept 6 (Reuters) - (This September 6 story corrected spelling of Fudan University from Furan in paragraph 5) A booster dose of Sinovac Biotech's (SVA.O), opens new tab COVID-19 vaccine ...

A study of a small Brazilian town vaccinated with the shot made by Sinovac Biotech Ltd. showed it can control Covid-19 outbreaks more effectively than expected from clinical testing, giving another ...

Concerns over the effectiveness of China’s Sinovac vaccine continue to grow—Indonesia reported hundreds of outbreaks among medical professionals who took the vaccine and hard-hit Costa Rica declined ...

China’s Sinovac claimed that a third dose of its Covid-19 vaccine is 94% effective against the omicron variant of the coronavirus, Nikkei Asia reported, in a statement the comes just a day after a ...

GENEVA, June 1 (Reuters) - The World Health Organization (WHO) said on Tuesday it has approved a COVID-19 vaccine made by Sinovac Biotech (SVA.O), opens new tab for emergency use listing, paving the ...